INBP — Integrated Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual balance sheet for Integrated Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.331	1.32	1.68	3.62	4.47
Net Total Accounts Receivable
Net Total Receivables	4.89	4.51	4.67	5.43	3.33
Total Inventory
Total Other Current Assets
Total Current Assets	16.6	16.4	17.9	18.8	17.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.78	4.28	3.67	2.75	4.83
Other Long Term Assets
Total Assets	25.3	25.4	26.2	24.9	25.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	5.26	4.83	6.12	4.25	5.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.67	6.57	6.97	4.58	7.67
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	18.6	18.9	19.2	20.3	17.7
Total Liabilities & Shareholders' Equity	25.3	25.4	26.2	24.9	25.3
Total Common Shares Outstanding